Standard Life Aberdeen »

Corbus Pharmaceuticals Hldgs shares owned by Standard Life Aberdeen

Quarter-by-quarter ownership of Corbus Pharmaceuticals Hldgs (CRBP) shares owned by Standard Life Aberdeen from 13F filings

Historical chart of Standard Life Aberdeen investment in Corbus Pharmaceuticals Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Corbus Pharmaceuticals Hldgs held by Standard Life Aberdeen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Corbus Pharmaceuticals Hldgs by Standard Life Aberdeen

Quarter filed Position value Share count Share price at filing
2024-03-31 $202k 5.1k 39.24

More positions owned by Standard Life Aberdeen

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Merck & Co (MRK)
UnitedHealth (UNH)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Procter & Gamble Company (PG)
Coca-Cola Company (KO)

View all positions for Standard Life Aberdeen

Top funds holding Corbus Pharmaceuticals Hldgs

Cormorant Asset Management
Point72 Asset Management
Ikarian Capital
Vanguard Group
Adage Capital Partners GP
Octagon Capital Advisors
Citadel Advisors
Henderson Group
Millennium Management
Assenagon Asset Management
BlackRock
T. Rowe Price Associates
Barclays
Morgan Stanley
Boothbay Fund Management

View all funds holding Corbus Pharmaceuticals Hldgs